Merck Set to Make a Killing with New Covid Drug

by Chris Black

There is no easy multibillion dollar profit to be made off readily available generic drugs. So Merck will get the approval to market a cancer causing worthless drug, because they can charge $700 for a treatment instead of the $2.75 Ivermectin costs. 

There is no such thing as healthcare. 

Only murder for profit.

Merck To Double Production Of 'Breakthrough' COVID Drug As Nations Line Up To Buy t.co/KSS2nPzp7K

— zerohedge (@zerohedge) October 12, 2021